These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15475822)

  • 41. Coronary Functional Abnormalities in Patients With Angina and Nonobstructive Coronary Artery Disease.
    Suda A; Takahashi J; Hao K; Kikuchi Y; Shindo T; Ikeda S; Sato K; Sugisawa J; Matsumoto Y; Miyata S; Sakata Y; Shimokawa H
    J Am Coll Cardiol; 2019 Nov; 74(19):2350-2360. PubMed ID: 31699275
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rho-kinase inhibition improves vasodilator responsiveness during hyperinsulinemia in the metabolic syndrome.
    Schinzari F; Tesauro M; Rovella V; Di Daniele N; Gentileschi P; Mores N; Campia U; Cardillo C
    Am J Physiol Endocrinol Metab; 2012 Sep; 303(6):E806-11. PubMed ID: 22829585
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases.
    Shimokawa H
    J Cardiovasc Pharmacol; 2002 Mar; 39(3):319-27. PubMed ID: 11862109
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rho-kinase inhibitor improves increased vascular resistance and impaired vasodilation of the forearm in patients with heart failure.
    Kishi T; Hirooka Y; Masumoto A; Ito K; Kimura Y; Inokuchi K; Tagawa T; Shimokawa H; Takeshita A; Sunagawa K
    Circulation; 2005 May; 111(21):2741-7. PubMed ID: 15927989
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The protein kinase inhibitor fasudil protects against ischemic myocardial injury induced by endothelin-1 in the rabbit.
    Yamamoto Y; Ikegaki I; Sasaki Y; Uchida T
    J Cardiovasc Pharmacol; 2000 Feb; 35(2):203-11. PubMed ID: 10672851
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Successful management of intractable coronary spasm with a coronary stent.
    Jeong MH; Park JC; Rhew JY; Kang KT; Lee SH; Cho JH; Kim NH; Kim KH; Ahn YK; Bae Y; Cho JG; Park JC; Kim SH; Kang JC
    Jpn Circ J; 2000 Nov; 64(11):897-900. PubMed ID: 11110439
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term treatment with a specific Rho-kinase inhibitor suppresses cardiac allograft vasculopathy in mice.
    Hattori T; Shimokawa H; Higashi M; Hiroki J; Mukai Y; Kaibuchi K; Takeshita A
    Circ Res; 2004 Jan; 94(1):46-52. PubMed ID: 14615290
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial.
    Shibuya M; Hirai S; Seto M; Satoh S; Ohtomo E;
    J Neurol Sci; 2005 Nov; 238(1-2):31-9. PubMed ID: 16005902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antianginal effects of hydroxyfasudil, a Rho-kinase inhibitor, in a canine model of effort angina.
    Utsunomiya T; Satoh S; Ikegaki I; Toshima Y; Asano T; Shimokawa H
    Br J Pharmacol; 2001 Dec; 134(8):1724-30. PubMed ID: 11739249
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new model of cerebral microthrombosis in rats and the neuroprotective effect of a Rho-kinase inhibitor.
    Toshima Y; Satoh S; Ikegaki I; Asano T
    Stroke; 2000 Sep; 31(9):2245-50. PubMed ID: 10978059
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic administration of an oral Rho kinase inhibitor prevents the development of vasculogenic erectile dysfunction in a rat model.
    Park K; Kim SW; Rhu KS; Paick JS
    J Sex Med; 2006 Nov; 3(6):996-1003. PubMed ID: 17100932
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Severe Coronary Artery Spasm after Coronary Artery Bypass Grafting;Report of a Case].
    Yamada S; Hirate Y; Kuwabara F; Ashida S; Yano D
    Kyobu Geka; 2019 Oct; 72(11):919-922. PubMed ID: 31588109
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Coronary-artery spasm after coronary artery bypass graft surgery without extracorporeal circulation: diagnostic and management.
    Carneiro Neto JD; Lima Neto JA; Simões RM; Stolf NA
    Rev Bras Cir Cardiovasc; 2010; 25(3):410-4. PubMed ID: 21103752
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fasudil is a superior vasodilator for the internal thoracic artery in coronary surgery.
    Watanabe G; Noda Y; Takagi T; Tomita S; Yamaguchi S; Kiuchi R
    Ann Thorac Surg; 2013 Aug; 96(2):543-7. PubMed ID: 23773733
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats.
    Li FH; Xia W; Li AW; Zhao CF; Sun RP
    Chin Med J (Engl); 2007 Jan; 120(1):22-9. PubMed ID: 17254483
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of fasudil on Rho-kinase and nephropathy in subtotally nephrectomized spontaneously hypertensive rats.
    Kanda T; Wakino S; Hayashi K; Homma K; Ozawa Y; Saruta T
    Kidney Int; 2003 Dec; 64(6):2009-19. PubMed ID: 14633123
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Spasm of the left main coronary artery resistant to intracoronary vasodilators. Apropos of a case].
    Guérin Y; Funck F; Desnos M; Sahnoun M; Hagege A; Aouate P; Guérot C
    Arch Mal Coeur Vaiss; 1992 Feb; 85(2):249-51. PubMed ID: 1562230
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Refractory spasm of coronary arteries and grafted conduits after isolated coronary artery bypass surgery.
    Lorusso R; Crudeli E; Lucà F; De Cicco G; Vizzardi E; D'Aloia A; Gelsomino S
    Ann Thorac Surg; 2012 Feb; 93(2):545-51. PubMed ID: 22206957
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats.
    Abe K; Shimokawa H; Morikawa K; Uwatoku T; Oi K; Matsumoto Y; Hattori T; Nakashima Y; Kaibuchi K; Sueishi K; Takeshit A
    Circ Res; 2004 Feb; 94(3):385-93. PubMed ID: 14670839
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhaled Fasudil Lacks Pulmonary Selectivity in Thromboxane-Induced Acute Pulmonary Hypertension in Newborn Lambs.
    Hanson SFL; Terry MH; Moretta DT; Power GG; Wilson SM; Alam F; Ahsan F; Blood AB; Giri PC
    J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):472-480. PubMed ID: 29756460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.